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Abstract
Using forward genetics, we have identified the genes mutated in two classes of zebrafish fin mutants. The mutants of the
first class are characterized by defects in embryonic fin morphogenesis, which are due to mutations in a Laminin subunit or
an Integrin alpha receptor, respectively. The mutants of the second class display characteristic blistering underneath the
basement membrane of the fin epidermis. Three of them are due to mutations in zebrafish orthologues of FRAS1, FREM1, or
FREM2, large basement membrane protein encoding genes that are mutated in mouse bleb mutants and in human patients
suffering from Fraser Syndrome, a rare congenital condition characterized by syndactyly and cryptophthalmos. Fin
blistering in a fourth group of zebrafish mutants is caused by mutations in Hemicentin1 (Hmcn1), another large extracellular
matrix protein the function of which in vertebrates was hitherto unknown. Our mutant and dose-dependent interaction
data suggest a potential involvement of Hmcn1 in Fraser complex-dependent basement membrane anchorage.
Furthermore, we present biochemical and genetic data suggesting a role for the proprotein convertase FurinA in zebrafish
fin development and cell surface shedding of Fras1 and Frem2, thereby allowing proper localization of the proteins within
the basement membrane of forming fins. Finally, we identify the extracellular matrix protein Fibrillin2 as an indispensable
interaction partner of Hmcn1. Thus we have defined a series of zebrafish mutants modelling Fraser Syndrome and have
identified several implicated novel genes that might help to further elucidate the mechanisms of basement membrane
anchorage and of the disease’s aetiology. In addition, the novel genes might prove helpful to unravel the molecular nature
of thus far unresolved cases of the human disease.
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Introduction
Fraser Syndrome (FS) is a recessive polygenic, multisystem
congenital human disorder characterised largely by syndactyly of
the soft tissue of the digits, cryptophthalmos (fusion of the eye lids)
and renal agenesis, although a myriad of other variable epithelial
malformations have been reported, underscoring the complex and
pleiotropic nature of the syndrome [1]. Autozygosity mapping and
candidate sequencing revealed that many Fraser syndrome cases
are due to mutations in the genes encoding the proteins FRAS1 or
FREM2, which belong to a family of large extracellular matrix
proteins [2,3,4]. This protein family contains two further
members, FREM1 and FREM3, however these have not, so far,
been implicated in Fraser Syndrome aetiology [5,6]. Our under-
standing of the molecular function of the FRAS1 and FREM
protein family has been aided by analysis of four mouse ‘bleb’
mutants [reviewed in 7]. The phenotypes of these mutants are
strikingly similar to the malformations seen in Fraser patients and
have long been considered to represent murine equivalents of
Fraser syndrome [8]. Indeed the ‘bleb’ mouse mutants have
recently been shown to correspond to mutations in the genes
encoding Fras1 [3,4], Frem2 [2] and Frem1 [6], as well as the
intracellular trafficking protein Grip1, required for correct basal
localisation of the Fras1 and Frem2 proteins [9]. The embryonic
expression domains of the Fras/Frem complex during develop-
ment coincide with sites later disrupted in the bleb mutants,
including the eye, the apical ectodermal ridges of the limb buds
and the kidney. Immunogold-labelling localised the proteins to the
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blistering and other defects [2,4,10,11]. As the blisters occur below
the lamina densa, it has been suggested that the Fras/Frem
proteins mediate adhesion of the basement membrane to the
underlying dermis [reviewed in 12]. Aside from the interactions
demonstrated between the Fras/Frem family members, other
ECM components to which the complex binds are unknown.
Identification of these interactions will elucidate the precise role
the Fras/Frem complex plays in maintaining adhesion. Further-
more, approximately 50% of the Fraser Syndrome patients have
no mutation in any of the candidate genes described, indicating
that other unidentified loci contribute to Fraser Syndrome.
Here, based on the genetic analysis of fin development in the
zebrafish [13], we identify several additional potential Fraser
syndrome disease genes. Teleosts possess two types of fins; the
paired fins including the pelvic and pectoral fins (homologues of
tetrapod hindlimbs and forelimbs respectively), and unpaired or
medial fins consisting of the dorsal, tail (caudal) and anal fins.
Whilst paired fins and appendages form from buds found at two
axial positions on the ventrolateral trunk, the medial fins are
derived from an initial continuous fin fold generated along the
midline at embryonic stages [14,15]. This fin fold is comprised of
two apposed sheets of bilayered epidermis, between which are
found numerous extracellular matrix structures including two
basement membranes, rod-like collagenous fibers called actino-
trichia, and extracellular cross fibres [16]. Outgrowth of both fin
types is mediated by the induction of a signalling structure, the
apical ectodermal ridge that is also present during tetrapod limb
growth [16,17].
To identify the molecules required for adhesion of the epidermis
during zebrafish fin outgrowth, we applied a combination of
chromosomal mapping, positional cloning and candidate testing of
ENU-induced mutations [13], revealing six essential proteins:
Laminina5, Integrina3, zebrafish orthologues of Fras1, Frem1,
Frem2, and Hemicentin1 (Hmcn1), the latter being an ECM
protein with hitherto unknown function in vertebrate biology.
Morphologically, and with respect to synergistic interactions, the
mutants fall into two classes, with Fras1, Frem1, Frem2 and
Hmcn1 displaying a characteristic formation of fin blisters at the
level of the lamina densa of the basement membrane, reminiscent
of the blistering seen in the limb buds of the mouse bleb mutants.
Very similar phenotypes and dose-dependent interactions were
obtained upon antisense-mediated loss of zebrafish orthologues of
the other mouse bleb genes (Grip1/2) and the ECM protein
Fibrillin2 [18], and upon mutations in the proprotein convertase
FurinA (sturgeon) [19]. Biochemical analyses further implicate Furin
in the proteolytic shedding of Fras1 and Frem2 from the cell
membrane. Together, we demonstrate that the zebrafish is a useful
model for elucidating mechanisms and novel players involved in
Fraser Syndrome, and that the Fraser complex is an ancient
invention with essential roles during the formation and/or
function of basement membranes in particular epithelial structures
of the developing embryo.
Results
Zebrafish fin mutants fall into two main phenotypic
classes
To elucidate the mechanisms required for generating fins, we
analysed zebrafish fin mutants isolated in previous [13] or more
recent ENU mutagenesis screens conducted in the Hammersch-
midt laboratory. Two main phenotypic classes could be distin-
guished by morphological criteria. One class, consisting of two
loci, fransen (fra) and badfin (bdf), was characterised by medial fins
that appeared ragged from about 30 hours post fertilisation (hpf)
and that became progressively dysmorphic, such that by 48 hpf the
fin fold was much reduced compared to wild-type (WT) embryos
(Figure 1K, 1L, 1M and Figure S1G, S1H, S1O, S1P, S1W, and
S1X). The pectoral fins were also dysmorphic in both mutants and
the yolk sac extension appeared thinner in fra at 48 hpf (Figure
S2A, S2H, and S2I; data not shown). The bdf mutant phenotype
appeared to be less severe than that of fra, and is homozygous
viable, with a proportion of bdf homozygous adults displaying
hypoplastic fins (compare Figure S2J with Figure S2N). fra
homozygous larvae however die at approximately 11 days post
fertilisation (dpf).
The second class of mutants, consisting of pinfin (pif), blasen (bla),
rafels (rfl) and nagel (nel), displayed characteristic temporary
blistering within the medial fins, starting between 26 and 32 hpf
(for pif, bla and nel) and noticeable at 48 hpf (Figure S1B, S1C,
S1D, S1E, S1F, S1J, S1K, S1L, S1M, and S1N; Figure 2A and 2B;
Figure 3A and 3B; Figure 4A and 4B; Figure 8A and 8B).
However, blisters were no longer visible at 120 hpf, when the fin
fold appeared slightly collapsed (Figure S1R, S1S, S1T, S1U, and
S1V). These defects were also mirrored in the pectoral fins, albeit
with a later onset, consistent with the later initiation of pectoral fin
bud formation (Figure S2A, S2B, S2C, S2D, S2E, and S2G).
There was a range of phenotypic severity among the different fin
blister mutants and alleles (for details see legend of Figure S1).
Blistering of the blood islands, leading to pooling of blood in the
ventral fin was observed in all pif mutants and occasionally in nel
mutants. bla was the least affected mutant, with blisters restricted
to the tip of the tail fin, whilst rfl displayed moderately large blisters
localised to the posterior portion of the medial fin. Uniquely rfl did
not display blistering until 48 hpf, appearing indistinguishable
from WT at 32 hpf (Figure S1E and S1M). With the exception of
the 3 strongest pif alleles (pif
b1130, pif
b1048, and pif
te262), which are
lethal at around 10–12 dpf, all fin blister mutants were viable. The
tail fin of adult homozyotes of the weak pif allele, pif
tm95, was mis-
patterned and had lost the bi-lobed structure (Figure S2J and
S2K). In contrast, adult bla, rfl and nel mutants displayed no overt
adult fin phenotype (Figure S2L, S2M, and S2N). The weak pinfin
Author Summary
There are a large number of human genetic syndromes
with limb and digit deformities. It has been shown that the
genes underlying these syndromes are well conserved in
evolution, and most perform the same role even in the fins
of fish. One such human syndrome is Fraser Syndrome,
characterized by a number of defects including fusion of
the fingers (syndactyly). Data obtained with corresponding
mouse mutants suggest that all of these defects are due to
transient basement membrane disruptions and epithelial
blistering during development. Whilst some of the Fraser
Syndrome genes have been identified, others are un-
known. We show that mutation of the known Fraser
Syndrome genes in zebrafish generate comparable blister-
ing defects in the fins. Importantly, we have also identified
additional genes and mechanisms required for the same
processes. Included in this are hemicentin1, a gene whose
function had thus far only been studied in nematodes, and
furinA, encoding a proprotein convertase, for which we
reveal a novel role in ectodomain shedding of Fras/Frem
proteins. This work thus expands our understanding, not
only of Fraser Syndrome, but also of the common
processes of basement membrane formation and function
during fin and limb development.
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PLoS Genetics | www.plosgenetics.org 2 April 2010 | Volume 6 | Issue 4 | e1000907Figure 1. The fin dysmorphogenesis of fransen and badfin mutants are caused by mutations in Laminina5 and Integrina3 subunits.
(A) Linkage analysis localised the fransen locus to LG23 close to the SSLP marker z59864, a region containing the lama5 gene. Here and in subsequent
figures, all markers north of the locus are represented in red, whilst those south in blue. Approximate genetic distances of markers relative to the
mutated locus (in centi Morgan), calculated by Kosambi’s mapping function, are given below each marker, with non-recombining markers indicated
by an asterisk. Location and relative orientation of candidate genes residing in the interval are depicted below the map as arrows, with the affected
gene coloured red. (B) Schematic of Laminina5 protein showing the domains of the protein, namely the signal peptide (pink bar), a laminin N-
terminal domain (green pentagon), laminin-type EGF-like domains (dark blue bars), an LF-like domain (orange oval), a laminin B domain (light blue
box), a coiled-coil domain (yellow box) and 5 laminin G domains (grey triangles). The location and molecular nature of the fransen
tc17 mutation is
given below. (C) Sequence chromatograms of lama5 cDNA from fra
tc17/tc17 mutant (right panel) and WT sibling (left panel). (D) Linkage analysis
localised the bdf
fr21/fr21 mutant to LG 12, near z6920. Candidate genes in the region were tested and itga3 was further characterised. (E) Protein
schematic of Itga3 protein showing the signal peptide (pink bar), 3 Integrin b-propellers (green boxes), an Integrin alpha domain (blue hexagon) and
a transmembrane domain (orange bar). The location and details of the bdf
fr21 and bdf
tz296 molecular lesions are given. (F) Sequence chromatograms
of itga3 cDNA from bdf
fr21/fr21 mutant (right panel) and WT sibling (left panel). (G) Phylogenetic tree of 5 different Integrin proteins from human,
mouse and zebrafish showing that the integrin mutated in bdf is a true Itga3 orthologue. (H) Protein ClustalW alignment showing that the bdf
fr21
mutation occurs in a residue (red asterisks) conserved across multiple Integrins in disparate vertebrates. Sequences are from top, zebrafish Itga3 from
bdf
fr21/fr21 mutant, wild-type zebrafish Itga3, human Itga3, mouse Itga3, human ItgaV, mouse ItgaV, zebrafish ItgaV, human Itga6, mouse Itga6,
zebrafish Itga6, human Itga7, mouse Itga7, human Itga9, mouse Itga9, zebrafish Itga7. (I–J) Lateral views of embryos stained by in situ hybridisation
with a probe for itga3 showing expression in the medial fin fold at 24 hpf (I) and in the pectoral fin (arrow) at 48 hpf along with expression in the
branchial arches and neuromasts (J). (K–N) Lateral Normaski images of the medial fin of a fra
tc17/tc17 embryo (K), a bdf
fr21/fr21 embryo (L), or an embryo
injected with a MO targeting the translation start of the itga3 mRNA at 48 hpf (N). The itga3 morphant displays moderate dysmorphogenesis of the
fin, highly reminiscent of the bdf
fr21/fr21 mutant at this stage and in contrast to uninjected control (M). (O–Q) Sequence chromatograms of itga3 cDNA
of bdf
tz296/tz296 mutant (O; lower panel), and WT sibling (O; upper panel), showing the deletion of 8 nucleotides in the mutant cDNA, and of itga3
genomic DNA of bdf
tz296/tz296 mutant (P; lower panel) and WT sibling (P; upper panel), showing the mutation of the splice acceptor site. (Q) illustrates
altered splicing at the exon 10 — exon 11 junction in bdf
tz296/tz296 mutant compared to WT sibling. Here and in subsequent figures, normal splicing is
shown as black lines joining the exon sequences (represented in uppercase). The intron sequences are in lowercase with the normal or cryptic splice
donor and acceptor sites underlined. The substituted base is shown in red above the WT base, with the mutated splice acceptor generating aberrant
splicing with use of a cryptic splice acceptor (illustrated as a red line).
doi:10.1371/journal.pgen.1000907.g001
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PLoS Genetics | www.plosgenetics.org 3 April 2010 | Volume 6 | Issue 4 | e1000907Figure 2. The fin blistering of pinfin mutants is caused by mutations in Fras1. (A–C) Injection of a morpholino targeting the translation site
of fras1 mRNA into wild-type embryos phenocopies the pif fin blisters; lateral views of tip of tail at 48 hpf; (A) uninjected control; (B) pif
te262/te262
mutant; (C) fras1 morphant. (D) Linkage analysis localised the pinfin locus to linkage group 5, close to the SSLP markers z6981 and z8122, neither of
which recombined with the locus, and between which the fras1 gene (depicted in red) was located. (E–H) Images of embryos stained by in situ
hybridisation using a probe against fras1. Close up view of the tail region of a 24 hpf embryo (E) and a 48 hpf embryo (F) are shown. The fras1 gene is
expressed in the medial fin fold, the pectoral fin fold (arrow in F; also see inset), the pronephric ducts (filled arrowhead in E) and the otic vesicle
(asterisks in F and insert). fras1 expression is also noted in the midbrain-hindbrain region at 24 hpf and 48 hpf (open arrowhead in G and F) and in the
pharyngeal pouches of the arches (H). (E–G) show lateral views, (H) a dorsal view. (I) Schematic of the predicted domain structure of zebrafish Fras1
protein, with a signal peptide (pink bar), von Willebrand C domains (green triangle), furin-like domains (red ovals), CSPG domains (orange diamonds),
Calx-bdomains (blue boxes) and a transmembrane domain (orange bar). Lesions found in four pif alleles are indicated above the protein schematic.
(J,L,M,O) Sequence chromatograms of fras1 cDNA from pif
te262/te262 (J), pif
b1130/b1130 (L), pif
b1048/b1048 (O), and pif
tm95/tm95 (M) mutants, displaying the
lesions depicted in (I). The frame shift (fs) mutation in pif
te262 is due to the insertion of the last 10 nucleotides of intron 42 (delineated with orange
lines). In all panels, the WT sibling chromatogram is given above the mutant chromatogram. (K) Chromatograms showing the genomic sequence at
the end of intron 42 of the fras1 gene in pif
te262/te262 (lower panel) and WT sibling (upper panel) embryos. The A.G substitution generates a novel
splice acceptor. (N) Representation of the exon 42-exon 43 junction with the mutation generating aberrant splicing (red line). (P) The glycine residue
(red asterisks) substituted in pif
tm95/tm95 is strictly conserved in both Fras1 and Frem2 proteins across diverse phyla, as seen in an alignment of the
region. Protein sequences are from top: zebrafish pif
tm95/tm95 mutant Fras1; zebrafish wild-type Fras1; fugu Fras1; human FRAS1; mouse Fras1; dog
Fras1; cow Fras1; chicken Fras1; sea urchin ECM3; zebrafish Frem2a; fugu Frem2a; human FREM2.
doi:10.1371/journal.pgen.1000907.g002
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tm95 was unique in that it showed a mild dominant larval
phenotype, characterized by a single small blister in the medial fin
fold (Figure S1Y and S1Z). Such combinations of partial loss-of-
function (hypomorphic) with dominant negative effects, contrast-
ing the purely recessive nature of amorphic (complete loss-of-
function) alleles, have been previously also observed for other gene
encoding proteins that act in homomeric complexes (see e.g. [20]).
Compromised fin morphogenesis of fransen and badfin
mutants is caused by mutations in Laminina5o r
Integrina3, respectively
Meiotic mapping placed the fra
tc17 mutation in the vicinity of
marker z59864 on linkage group 23 (Figure 1A), the same region
to which the m538 mutation in the laminina5 (lama5) gene has been
recently mapped [21]. Sequencing the lama5 coding region from
cDNA made from fra
tc17/tc17 mutants (Genbank accession number
GU936670) revealed an 9034A.T nonsense mutation, leading to
a premature truncation of the protein at amino acid residue 3012
(Figure 1B and 1C) and a protein that lacks most of the C-terminal
Laminin G domains required for receptor binding. Consistently,
injection of a previously described antisense morpholino oligonu-
cleotide (MO) directed against a splice site of the lama5 gene
(predicted to mimic the fra
tc17 mutation, also resulting in loss of the
C-terminus of the protein [21]) yielded embryos displaying fin
dysmorphogenesis as in fra mutants (data not shown). Together,
this strongly suggests that fra represents an allele of m538, and that
the fin dysmorphogenesis of fra mutants is caused by loss-of-
function mutations in the laminina5 gene.
We next cloned the bdf mutation, which complements fra and
thus represents another locus required for normal fin develop-
ment. Rough mapping placed the mutation between markers
z8947 and z27025 of LG 12, in the vicinity of z6920 (Figure 1D).
The interval contains a gene encoding the zebrafish orthologue of
Integrina3( itga3; Figure 1G; Genbank accession number
GU936669), a subunit of the a3b1 dimer, a known receptor for
Figure 3. The fin blistering of the blasen mutant is caused by mutation of Frem2a. (A–C) Injection of a morpholino targeting the translation
site of frem2a mRNA into WT embryos phenocopies the bla fin blisters; lateral views of posterior medial fin, 48 hpf; (A) uninjected control; (B)
bla
ta90/ta90 mutant; (C) frem2a morphant. (D) Genetic map (set out as in Figure 1A), showing the approximate location of the blasen locus on linkage
group 10 between markers z9328 and z7504, with genes within this interval shown below, including the strong candidate frem2a (red arrow). (E,F)
Lateral views of embryos at 24 hpf (E) and 48 hpf (F) stained by in situ hybridisation for frem2a, revealing expression in the medial and pectoral fin
fold (arrow, F). (G) Schematic of the zebrafish Frem2a protein with conserved domains as in Figure 2I, and the position and nature of the bla
ta90
mutation indicated. (H) Sequence chromatograms of frem2a cDNA from bla
ta90/ta90 mutants (lower panel) and heterozygous siblings (upper panel)
showing the missense mutation depicted in (G). (I) Protein sequence alignment of Fras and Frem proteins showing the absolute conservation of the
arginine residue mutated in bla
ta90 (red asterisks) across different vertebrate classes. Sequences from the top are: zebrafish bla
ta90/ta90 mutant Frem2a;
zebrafish wild-type Frem2a; zebrafish Frem2b; zebrafish Frem3; human FREM2; mouse Frem2; zebrafish Fras1; fugu Fras1; human FRAS1; mouse Fras1;
zebrafish Frem1a; human FREM1; mouse Frem1. (J) Segregation linkage analysis: the bla
ta90 mutation generates a BccI site, which is present in both
alleles of all bla homozygotes (lanes 7–48), whilst wild-type siblings (lanes 1–6) show at least one copy of the uncut allele; lane 49, 100 bp ladder.
doi:10.1371/journal.pgen.1000907.g003
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we considered itga3 to be an excellent candidate for bdf. Indeed, in
situ hybridisation revealed itga3 expression in the median fin fold
at 24 hpf, as well as in the pectoral fin at 48 hpf, sites affected in bdf
mutants (Figure 1I and 1J). In addition, abolishing Itga3 levels
through injection of wild-type embryos with MOs targeting either
the translational start site of itga3 mRNA or the splice donor site of
exon 3, we obtained mild medial fin dysmorphogenesis
(Figure 1N), reminiscent of the bdf phenotype (Figure 1L). Finally,
we sequenced the itga3 coding region from the two bdf alleles, fr21
and tz296. The bdf
fr21 allele harboured a 1279T.C mutation in
the coding region (Figure 1F), leading to a substitution of a serine
residue that is conserved across many Integrin alpha subunits of
multiple species (Figure 1E and 1H). The bdf
tz296 cDNA displayed
a deletion of 8 nucleotides in the middle of the itga3 coding region,
resulting in a frameshift and predicted to result in the inclusion of
5 aberrant amino acids (IYDRC) and a premature termination of
the protein directly before the integrin alpha domain (Figure 1E).
Sequencing of genomic DNA further revealed that the deleted 8
nucleotides corresponded to the first 8 base pairs of exon 10, and
that bdf
tz296/tz296 embryos had a G.A substitution at the final base
of intron 10 (Figure 1P), abolishing the splice acceptor and forcing
use of a cryptic splice acceptor within exon 11 (Figure 1Q). Taken
together these data demonstrate that itga3 is required for
appropriate fin morphogenesis.
Due to the similarity of phenotype and their known direct
physical interaction in vitro, we hypothesised that itga3 and lama5
might act synergistically in vivo. We tested this by co-injecting sub-
phenotypic doses of MOs directed against both genes. Although
individually, these MOs did not elicit a phenotype at these
respective concentrations, co-injection generated embryos display-
ing compromised fin morphogenesis (Figure S3A, S3B, S3C, and
Figure 4. The fin blistering of rafels mutants is caused by mutations in Frem1a, which shows partial functional redundancy with
Frem1b. (A–C) The rafels mutant displays mild blistering of the posterior fin at 48 hpf (B) compared to a sibling (A), and is phenocopied in wild-type
embryos by injection of a morpholino targeting frem1a (C). Lower panels show dorsal views tail fin, providing a more striking image of the blistering
in the mutant and morphant. (D,E) Expression of frem1a in the medial fin fold at 24 hpf (D) and pectoral fin at 48 hpf (D-inset). Expression of frem1b is
weaker but can be seen in the tail region, in particular in the blood islands, at 24 hpf (E). (F) Genetic map (set out as in Figure 1A), showing the
approximate location of the rafels locus on linkage group 7 between markers z9249 and z13880. Independent radiation hybrid mapping localised the
frem1a gene to this region, with distances to the mapping markers given in grey. (G) Schematic of the zebrafish Frem1a protein with conserved
domains as defined in Figure 2I. The purple circle depicts the C-type Lectin domain. The positions and natures of the molecular lesions of the rfl
tc280b,
rfl
fr23 and the rfl
tr240 alleles are indicated. (H–L) Sequence chromatograms of the mutations in the frem1a cDNA of rfl
tc280b/tc280b (H), rfl
fr23/fr23 (I), and
rfl
tr240/tr240 (J) (lower panels) compared to wild-type siblings (upper panels). The 13 nucleotide insertion in the rfl
tr240/tr240 allele is delineated by orange
lines (J). Genomic sequencing of the intron32-exon33 boundary reveals generation of a novel splice site in the rfl
tr240/tr240 mutants (K; lower
chromatogram), leading to aberrant splicing as depicted in (L) (red lines). (M–P) frem1b splice MO enhances the rafels phenotype. Lateral views of WT
(M) or rfl
fr23/fr23 (N–P) embryos either uninjected (N) or injected with frem1b splice MO (M,O,P) photographed at 32 hpf (M–O) or 48 hpf (P). Whilst the
frem1b MO does not generate a phenotype alone (M), it reveals a blistering phenotype in rafels mutants at 32 hpf (O), a time when a phenotype is not
seen in uninjected mutants (N). The frem1b MO injected frem1a mutants often display degeneration of the fin at 48 hpf (P; compare to B).
doi:10.1371/journal.pgen.1000907.g004
Fraser Syndrome in Zebrafish
PLoS Genetics | www.plosgenetics.org 6 April 2010 | Volume 6 | Issue 4 | e1000907S3D; Table 1) identical to that of fra (Figure 1K) or bdf (Figure 1L)
mutants. This provides evidence that Itga3 and Lama5 function in
the same pathway during zebrafish fin development in vivo,
consistent with their physical interaction.
The fin blistering of pinfin, blasen, and rafels mutants is
caused by mutations in Fras1, Frem2a, and Frem1a,
respectively
Chromosomal mapping approaches were also undertaken to
determine the underlying genetic defects of the fin blister mutants.
We mapped the pif
tm95 allele to LG5 between the markers z9815
and z31983 (Figure 2D). One of the genes within the correspond-
ing interval was the zebrafish orthologue of the human Fraser
syndrome gene FRAS1, mutations in which lead to similar
epidermal blistering (see Introduction). Interestingly, the bla
ta90
mutation mapped to an interval of LG10 (between markers z9328
and z7504), which contains frem2a, a zebrafish homologue of
FREM2 (Figure 3D), the second Fraser syndrome gene in human.
Concomitantly we localised the frem1a gene (an orthologue of
FREM1) to LG7 via radiation hybrid mapping, noting that it co-
mapped to the region corresponding to the rafels fin blistering
mutant (Figure 4F). Whole mount in situ hybridisations revealed
prominent expression of zebrafish fras1, frem2a and frem1a in the
apical region of the median fin fold epithelium at 24 hpf, before
the fin phenotype becomes apparent in pif, bla and rfl mutants
(Figure 2E, Figure 3E, and Figure 4D). In addition, these genes
were expressed in the apical ridge of the pectoral fin and in the
pharyngeal arch region (Figure 2F and 2H; Figure 3F; Figure 4D).
fras1 additionally showed expression in the hypochord, somites,
pronephric ducts and midbrain-hindbrain region at 24 hpf
(Figure 2E and 2G), whilst also being expressed in the ear at 48
hpf (Figure 2F).
By sequencing fras1 cDNA (Genbank accession number
GU936658) from four different pif alleles, frem2a cDNA (Genbank
accession number GU936661) from the single bla allele and frem1a
cDNA (Genbank accession number GU936659) from three rfl
alleles, we identified molecular lesions leading to premature
truncations of the corresponding proteins, or the substitution of
evolutionary conserved amino acid residues. pif
b1130 displayed a
7231G.T mutation in the fras1 coding region, resulting in a
premature translational termination after amino acid residue
2410, and pif
b1048 contained a 10642C.T transversion generating
a premature stop codon at amino acid residue 3548 (Figure 2I, 2L,
and 2O). pif
te262 mutants showed an A to G transversion in intron
42, 11 bp upstream of the normal start of exon 43, generating a
new and preferentially used splice acceptor site. Accordingly,
cDNA from mutant embryos contained an insertion of the last 10
base pairs of intron 42, leading to a frame shift and an inclusion of
16 aberrant amino acids (FFIAHQRGPSSNYLCK), followed by a
stop codon, at amino acid residue 1949 (Figure 2I, 2J, and 2N).
Finally, pif
tm95b displayed a 11446G.T missense mutation, leading
to the substitution of a totally conserved glycine residue at amino
acid 3816 with a tryptophan (Figure 2I, 2M, and 2P). Similarly,
sequencing the frem2a coding region from bla
ta90 homozygotes, we
identified a single 5209C.T mutation that results in the exchange
of a strictly conserved arginine residue at amino acid position 1737
by a tryptophan (Figure 3G–3I). This mutation generated a
restriction fragment length polymorphism, which we used for
direct segregation linkage analysis, revealing co-segregation of the
frem2a mutation and the bla phenotype in 160/160 investigated
meioses (Figure 3J). Finally, we identified mutations in the frem1a
coding region in rfl alleles. rfl
tc280b harboured a 1491T.A
mutation in the cDNA resulting in the conversion of the triplet
encoding tyrosine 497 to a stop codon (Figure 4G and 4H).
Similarly, the rfl
fr23 allele displayed a 2487T.A mutation leading
to a premature stop codon at amino acid position 829 (Figure 4G
and 4I), whilst the frem1a cDNA sequence from the rfl
tr240 mutant
fish had a 13 nucleotide insertion corresponding to the last
nucleotides of intron 32 of the frem1a gene (Figure 4J). This
insertion leads to a frame shift, inclusion of 20 amino acids
(VSVSDVLQALFSRSLRSPAL) and premature termination of
the protein. Consistently, the genomic DNA of rfl
tr240 mutants
displayed a T.A mutation in intron 32, 15 base pairs upstream of
the junction with exon 33, generating a novel and preferentially
used splice acceptor site (Figure 4K and 4L).
We could reproduce the pif, bla and rfl fin blister phenotypes in
wild-type embryos by MO-mediated knock-down of fras1, frem2a
or frem1a. The defects of fras1, frem2a and frem1a morphants were
indistinguishable from those of the pif, bla and rfl mutants,
respectively (compare Figure 2C and 2B, Figure 3C and 3B, and
Figure 4C and 4B). We also confirmed the fras1 and frem1a splice
MO results using second MOs targeting the translation start sites
of these genes (Figure S4A and S4B). Together, this indicates that
the zebrafish homologues of the human disease genes Fras1,
Frem2 and Frem1 are indispensable during zebrafish fin
development.
Mouse Fras1 and Frem2 have been shown to interact in vitro
and are suggested to reciprocally stabilise each other within the
basement membrane [23]. Consistent with this, we found that co-
Table 1. Synergistic interaction between itga3 and lama5.
uninjected control itga3 ATG MO 1:20 lama5 splice MO 1:150
itga3 ATG MO 1:20 + lama5
splice MO 1:150
CSCSCSCS
WT fin (%) 100 100 96 96 100 100 61 36
single blister (%) 0 0 0 0 0 0 0 0
multiple blisters (%) 0 0 0 0 0 0 0 0
degenerate fins (%) 0 0 4 4 0 0 39 64
n 3 46 82 55 42 75 93 13 3
For each experimental treatment, numbers of embryos seen in the 4 phenotypic classes (WT fin, single blister, multiple blisters and degenerate fins) were assessed at 48
hpf. 1:xx values indicate injected dilution of 1 mM stock of used morpholino. Combined injections of morpholinos were performed in two ways, either co-injection of a
mixture of morpholinos at the given doses, or sequential injection of the two morpholinos separately. Independent controls were done for both methods and each
treatment is presented with two sub-columns of numbers for co-injection (C) and sequential injection (S). Numbers of embryos within one of the four different
phenotypic categories (rows 1–4) are given in percent (%), total numbers of evaluated embryos per experiment (n) in row 5.
doi:10.1371/journal.pgen.1000907.t001
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upon single injections did not cause apparent defects, yielded
severe blistering of the fins comparable to that of pif mutants or
embryos injected with highest MO amounts (Figure S3E, S3F,
S3G, and S3H; Table 2). This synergistic enhancement of defects
caused by partial loss of each of the two players is in line with a
cooperation of Fras1 and Frem2a during normal fin development.
Antisense-mediated inactivation of zebrafish Frem1b,
Frem2b, and Frem3 proteins reveals partial functional
overlap of zebrafish Fraser complex paralogues
As described above, the blistering phenotypes of frem1a (rfl) and
frem2a (bla) mutants are significantly weaker or become apparent
significantly later than those of fras1 (pif) mutants, suggesting
partial functional redundancy among Frem1 and Frem2 proteins.
Performing BLAST searches of different zebrafish databases, we
identified 3 further members of the Fras/Frem family, which,
according to our own phylogenetic analyses and recently published
data by the Smyth laboratory [24], have been named frem1b,
frem2b and frem3, whereas no second fras1 paralogue could be
identified. At 24 hpf, strong fin fold expression similar to that of
fras1 and frem2a was evident for frem3 (Figure 5D), whereas frem2b
expression in the fin fold could only be detected starting at the
second day of development (Figure 5C). Expression of frem2b was
also noted in the pronephric ducts at 24 hpf (Figure 5A), as well as
the blood islands at 32 hpf (Figure 5B). Expression of frem1b in the
fin folds was comparably weak and diffuse, while more prominent
expression was noted in the blood islands at 24 hpf (Figure 4E) and
in the developing vasculature of the head and in the intersomitic
boundaries at 5 dpf (data not shown). To understand if these genes
also play a function in maintaining fin morphology, we designed
MOs against them. Whilst injection of either a splice or ATG MO
targeting frem1b into WT embryos did not elicit a discernable
phenotype, when injected into rfl
fr23/fr23 (frem1a) mutant embryos,
both of these MOs enhanced the blistering phenotype signifi-
cantly, with blisters also appearing much earlier (at 32 hpf;
Figure 4M, 4N–4O, Figure S4C). These blisters seemed quite
unstable, and in many cases collapsed by 48 hpf to give the fin a
dysmorphic appearance (compare Figure 4P with Figure 4A–4C).
Injection of MOs targeting the translation start site of frem2b and
frem3 revealed both functional redundancy with frem2a and
regional sub-functionalisation. We noted that while bla
ta90/ta90
(frem2a) mutants displayed small blisters restricted to the posterior
medial fin at 32 hpf (Figure 5F), frem2b morphants had large
Table 2. Synergistic interaction between frem2a and fras1.
uninjected control frem2a ATG MO 1:60 fras1 ATG MO 1:4
frem2a ATG MO 1:60 +
fras1 ATG MO 1:4
CSCSCSCS
WT fin (%) 100 100 94 98 96 80 33 42
single blister (%) 004042 0 1 6 1 6
multiple blisters (%) 0000003 2 2 1
degenerate fins (%) 0022001 9 2 1
n 79 91 51 101 57 61 109 66
For more information, see Table 1.
doi:10.1371/journal.pgen.1000907.t002
Figure 5. Partially redundant roles of zebrafish Frem2/3 paralogues. In situ hybridisation of embryos using probes against frem2b (A–C), and
frem3 (D) at 24 hpf (A, D), 32 hpf (B), and 48 hpf (C). Expression of frem3 in the fin fold can be seen at 24 hpf (D), whilst expression at this site only
commences at 48 hpf for frem2b (C). frem2b is also expressed in the blood islands at 32hpf (arrowhead, G) and in the pronephric ducts from 24 hpf
(arrowheads in A; dorsal view). (E–N) Lateral views of 32 hpf WT embryos (E,G,J,L), bla
ta90/ta90 embryos (F,H,K,M) or pif
tm95/tm95 embryos (I,N) which are
either uninjected (E,F,I), or injected with morpholinos targeting frem2b (G,H), frem3 (J,K,N) or a mix of morpholinos against frem2b and frem3 (L,M).
Blistered regions of the fin and blood islands are highlighted by bars and arrows respectively which are coloured green in bla mutants, red in frem2b
morphants and blue in pif mutants.
doi:10.1371/journal.pgen.1000907.g005
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anterior to the tail tip, sites unaffected in bla mutants (Figure 5G;
confirmed with an independent 59UTR directed MO, Figure
S4D). Injecting the frem2b MO into bla
ta90/ta90 embryos had an
additive effect, with larvae showing small blisters at the tail tip and
blisters in the blood islands and dorsal regions (Figure 5H). In
contrast to the frem2b MO, injection of the frem3 MO alone did not
yield an appreciable phenotype (Figure 5E and 5J), despite high
frem3 expression in the fin fold. We hypothesised that the function
of Frem3 may be redundant with other Fraser genes expressed in
the fin fold. However knockdown of frem3 in either frem2b
morphants or pif mutants failed to enhance their respective
phenotypes appreciably (compare Figure 5L and 5G, and
Figure 5N and 5I). In contrast, knockdown of frem3 in bla
ta90/ta90
embryos with either an ATG or splice MO, visibly enhanced the
severity of the bla fin blisters, with anterior expansion of the
blistered region (compare Figure 5K and Figure S4E with
Figure 5F), but generally without significant blistering of the
blood island region (Figure 5K). Finally, triple abrogation of both
frem2 paralogues and frem3 resulted in embryos phenotypically
indistinguishable from pif mutants (compare Figure 5M and 5I),
consistent with the identical phenotypes of the mouse Fras1 and
Frem2 mutants. However, embryos deficient in Fras1, Frem2a,
Frem2b and Frem3, were no more severely affected than either pif
mutants alone or the Frem2a, Frem2b and Frem3 triple deficient
embryos (Figure S3Y, S3Z, S3AA, and S3AB). Together, this
suggests that Frem1a acts in partial functional redundancy with
Frem1b, and Frem2a in partial redundancy with Frem2b and
Frem3, partially compensating for each other as interaction
partners of Fras1.
Grip1 and Grip2 have partially redundant roles to avoid
fin blister formation in zebrafish
It has been shown in mouse studies that the intracellular
trafficking proteins Grip1 and Grip2 are required for localisation
of Fras1 and Frem2 to the basal cell membrane, and that Grip1,
Grip2 double mutant mice resemble Fras1 mutant mice [9]. We
identified zebrafish orthologues of both Grip1 and Grip2 and
analysed their expression pattern to determine if their role in
trafficking Fras1 and Frem2 is conserved. We found that grip1 was
expressed in an identical pattern to both fras1 and frem2a, including
the fin fold (Figure 6A), whereas grip2 displayed rather ubiquitous
expression, preceded by maternal transcript localised vegetally, as
reported for Xenopus XGrip2 (Figure 6B and 6C) [25]. Upon
injection of wild-type embryos with a grip1 splice MO, we failed to
observe any fin phenotype (Figure 6D and 6E). However, injection
of MOs targeted to either the ATG or 59UTR of Grip2 generated
mild blistering of the fin (Figure 6F; data not shown). Finally,
simultaneous injection of both the Grip1 splice MO and the Grip2
ATG MO produced severe blistering in the fin (Figure 6G), similar
to that of pif mutants or Frem2a/2b/3 triple deficient embryos.
This was confirmed with co-injection of the Grip1 ATG MO and
Grip2 59UTR MOs (Figure S4F). Thus, as in mouse, the Grip
proteins display partially redundant functions, and the blistering
seen upon their loss points to a conserved role of the Grip1 and 2
proteins in localising Fraser complex proteins in zebrafish.
FurinA synergistically interacts with Frem2a, and it is
required for ectodomain shedding of Fras1 and Frem2 in
vitro and for proper Fras1 localization in vivo
The zebrafish craniofacial mutant sturgeon (stu) in the proprotein
convertase FurinA also displays mild blisters in the median fin
folds (Figure 7A and 7B) [19,26]. Consistently, furina displayed
prominent expression in the apical median fin fold of 24 hpf wild-
type embryos (Figure 7C and 7D). Interestingly, Fras1 and Frem2
proteins, in contrast to Frem1, contain C-terminal transmembrane
domains. However, recent in vitro studies have shown that both
can be shed from the cell membrane, while the proteases
potentially mediating this effect remained unknown [23]. We
identified conserved Furin consensus cleavage sites in the zebrafish
Fras1 and Frem2a protein sequences (Figure 7E). These occurred
in both proteins immediately N-terminal to the predicted
Figure 6. Conserved and redundant roles of zebrafish Grip1/2 proteins. Lateral views of embryos stained by in situ hybridisation with
probes against grip1 (A) and grip2 (B,C) at 2-cell stage (B) and 24 hpf (A,C). grip1 is expressed in the fin fold (A) whilst grip2 is broadly expressed at 24
hpf (C). grip2 is maternally deposited in a vegetal domain (B). (D–G) Lateral views of an uninjected WT embryo (D) or embryos injected with
morpholinos against grip1 (E), grip2 (F) or both grip1 and grip2 (G) at 32 hpf, demonstrating that whilst grip2 can fully compensate for loss of grip1
function in fin fold integrity (E), loss of grip2 alone (F), or combined loss of both proteins (G) generates moderate to severe fin fold blistering
respectively.
doi:10.1371/journal.pgen.1000907.g006
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PLoS Genetics | www.plosgenetics.org 9 April 2010 | Volume 6 | Issue 4 | e1000907Figure 7. Furin is required for basement membrane anchorage, ectodomain shedding and proper basement membrane localisation
of Frem2 and Fras1 proteins. (A,B) Lateral views of the medial fin of a sturgeon mutant at 48 hpf (B) showing mild blistering reminiscent of pinfin
and blasen mutants compared to a sibling (A). (C,D) In situ hybridisation analysis of furina demonstrates broad expression in the embryo at 24 hpf (C)
with clearly increased levels in the fin fold (D). (E) A consensus Furin cleavage site (red box) is conserved in Fras1 immediately N-terminal to the
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Frem2a to a mature form, we would expect them to interact dose-
dependently. We tested this by injecting sub-phenotypic doses of
morpholinos against furina and frem2a, and were indeed able to
induce fin blisters when combining doses of the MOs that
individually gave no phenotype (Figure 7F, 7H, and 7I; Table 3).
We then used a previously reported in vitro biochemical assay
[23], which demonstrated that both murine Fras1 and Frem2 are
released into the medium of transfected 293F cells. This cell line
expresses Furin endogenously (data not shown) (Figure 7J). The
relative amount of Fras1 and Frem2 protein in the medium was
significantly reduced after addition of the Furin/Proprotein
convertase inhibitor Decanoyl-RVKR-CMK, while cellular pro-
tein levels remained unaffected (Figure 7J). This indicates that
membrane shedding of both proteins is indeed dependent on Furin
or a related Proprotein convertase. The similar phenotypes of
fras1, frem2a and furina mutants further suggest that such Furin-
dependent ectodomain shedding of Fras1 and Frem2a is essential
for their role to ensure proper basement membrane integrity.
To further assess the role of Furin in Fras1 shedding in the
zebrafish fin, we used a transplantation approach to track the
behaviour of the Fras1 protein and its dependence on FurinA in
vivo. First, GFP-positive wild-type cells were transplanted into
Fras1-deficient pif mutant hosts, followed by immunofluorescence
stainings on transverse sections through median fins with a
polyclonal antibody raised against zebrafish Fras1 (see Materials
and Methods). In non-chimeric wild-type embryos, Fras1 protein
was present below the epidermal sheets of the median fin
(Figure 7O), consistent with the reported localization of mouse
Fras1 to basement membranes [23]. Since the pif
te262/te262 host
cells fail to generate Fras1 (the pif
te262 allele is a nonsense mutation
N-terminal to the region used to raise the antibody; see also
below, Figure 9I), all protein detected by the antibody in wild type
. pif chimeras must originate from the transplanted, GFP-
labelled wild-type cells. Indeed, we only detected anti-Fras1
signals associated with transplanted cells. However, in case of
transplanted wild-type cells, Fras1 signals were not restricted to
the region of the basement membrane directly underlying the
transplanted cells, but found in a significantly larger portion of the
basement membrane, extending several cell diameters proximally
(but not distally) of the donor cells (Figure 7K; n=38/41; 4
embryos). This suggests that Fras1 is shed from the surface of the
donor cell to undergo some kind of directed unilateral displace-
ment within the basement membrane (see also below). Identical
transplantation experiments with Furina-deficient, rather than
wild-type donors, further revealed that this displacement requires
the donor cell to express FurinA Thus, in contrast to Fras1 from
transplanted wild-type cells, Fras1 derived from cells of stu mutant
donors injected with moderate amounts of furina MO did remain
closely attached to the basal cell surface, pointing to a lack of
shedding (arrowhead in Figure 7L; n=24/24; 2 embryos).
Corresponding shifts in the localisation of Fras1 protein were
also observed in non-mosaic stu mutants. Whereas in wild-type
siblings, Fras1 protein was found in the basement membrane
throughout the entire proximo-distal extent of the median fins
(Figure S5A; see also below), it was restricted to more distal
regions in stu mutants (Figure S5B). Together, this suggests that
FurinA acts as a Fras1 sheddase, and that this shedding is a
prerequisite for the relative proximal-wards displacement of Fras1
protein within the forming median fins.
Table 3. Synergistic interaction between frem2a and furina.
uninjected controls frem2a ATG MO 1:80 furina ATG MO 1:80
frem2a ATG MO 1:80 +
furina ATG MO 1:80
CSCSCSCS
WT fin (%) 100 100 100 98 100 73 39 32
single blister (%) 000102 3 91 4
multiple blisters (%) 0000024 0 4 9
degenerate fins (%) 0001021 2 5
n 59 76 43 100 33 95 77 87
Embryos were assessed at 30 hpf. For more information see Table 1.
doi:10.1371/journal.pgen.1000907.t003
transmembrane domain across vertebrates. (F–I) furina and frem2a interact dose-dependently in zebrafish. Embryos injected with sub-phenotypic
doses of morpholinos targeting frem2a (G) or furina (H) have medial fins as uninjected control embryos (F) at 48 hpf. Combined injection of the two
MOs at these doses robustly induces single or multiple blisters of the fins (I). (J) Chemical inhibition of Furin function (far right lanes in all panels)
reduces secretion of N-terminally 3xHA tagged Fras1 protein (upper left panel) and of N-terminally 3xMyc tagged Frem2 protein (upper right panel)
from 293F cells into the medium. Proteins were detected by Western Blotting with an anti-HA antibody (for the Fras1 construct) or an anti-myc
antibody (for the Frem2 construct). Cellular expression levels were not affected by addition of the inhibitor (lower panels). Due to the large size of the
proteins and the small size of the cleaved C-terminus, the differences in sizes between the cellular and secreted proteins are indistinguishable. (K,L)
Transverse sections of the posterior medial fin of 42 hpf pif
te262/te262 embryos at 42 hpf, after transplantation of GFP-positive cells from either a WT (K)
or a sturgeon mutant (L) donor at 6 hpf. The sections were immunostained for Fras1 (red), p63 (pink) and GFP (green), and nuclear DNA was
counterstained with DAPI (blue). Fras1 protein from WT cells can be found in the basement membrane several cell diameters proximal of its source
(white bar in K). In contrast, Fras1 from stu mutant cells lacking FurinA remains restricted to the basal surface of the donor cell (arrowhead, L). (M–P)
Transverse sections through tail of embryos at 24 hpf (M) or 30 hpf (N–P) showing localisation of fras1 mRNA by in situ hybridisation (M,N,P: blue
precipitate) compared to Fras1 protein (O: red precipitate, P: brown precipitate). Fras1 protein is present in the basement membrane along the entire
fin fold (O,P), whereas fras1 mRNA is largely restricted to apical cells of the fin fold (M,N,P). Apical restriction is more pronounced at 30 hpf (N), while
at 24 hpf, the fras1 expression domain appears to extend further proximally (M). (Q,R) Cell tracing analysis after transplantation of GFP-labelled,
tg(bactin::hras-egfp) transgenic presumptive epidermal cells into non-transgenic hosts. Comparison of labelled cells in the same chimeric embryos at
24 hpf (Q) and 48 hpf (R) revealed that proximal clones had approximately doubled their cell number, whilst distal cells had not proliferated, but had
increased their surface area by acquiring a flat elongate shape.
doi:10.1371/journal.pgen.1000907.g007
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basement membranes is broader than the expression
domain of the fras1 gene
Data consistent with such a proximal-wards displacement of
Fras1 protein were also obtained when directly comparing the
distribution patterns of fras1 mRNA and Fras1 protein. At 30 hpf
Fras1 protein was found along the entire proximo-distal extent of
fin (Figure 7O and 7P), consistent with the proximal extension of
the fin blisters in mutant embryos (see above). In contrast, fras1
RNA was strictly confined to the apical-most epidermal cells of the
fin folds (Figure 7N and 7P). Aside from the displacement of Fras1
protein relative to the overlying cells mentioned above, a second
explanation for this proximally extended distribution of Fras1
protein could be apical growth of the fin fold, whereby
descendents of fras1-positive distal cells would give rise to more
proximal fin fold epithelia, carrying closely associated Fras1
proximally as they generate the proximal fin. To test this notion,
we performed in vivo cell tracing experiments with clones of
fluorescently labelled ectodermal cells. However, in none of our
recorded cases (0/6) did cells located in apical ectodermal ridges at
24 hpf give rise to more proximal fin cells at 48 hpf (Figure 7Q and
7R). Rather, fin extension seemed to be driven by uniform growth
along the entire proximo-distal axis of the fin or by preferential
proliferation of epidermal cells in more proximal positions. This
rules out apical-driven growth as a mechanism for proximally
extended Fras1 protein distribution. A third explanation could be
dynamics in the fras1 expression pattern in combination with high
Fras1 protein stability. Indeed, we noted that in transverse sections
at earlier stages, the fras1 RNA expression domain extended more
proximally than later (compare Figure 7N with Figure 7M).
Together, these results suggest that Fras1 protein is distributed in
the basement membrane along the entire proximal-distal fin axis,
which may be accounted for by high stability of Fras1 protein
deriving from the initially broader RNA expression domain,
coupled with proximal growth of the fin fold epidermis over
basement membrane material deposited by apical cells, and/or
directed proximal-wards motility of shed Fras1 protein within the
basement membrane.
The fin blistering of nagel mutants is caused by
mutations in Hemicentin1 (Hmcn1)
We next turned our attention to the last fin blister mutant, nagel
(nel; Figure 8A and 8B). Despite showing strong blistering, with
onset at a similar time to pif and bla, nel appears slightly weaker
than pif and only occasionally shows blisters in the blood islands
(Figure S1F, S1N and S1V). We mapped the nel
tq207 mutation to
LG20, close to marker z35375, but distant from all annotated fras/
frem/grip genes (Figure 8D). One of the genes located within the
interval was hemicentin1 (hmcn1; Genbank accession number
GU936666), which encodes a large multidomain ECM protein
of the Fibulin family, the function of which has thus far solely been
investigated in the nematode C. elegans. In this organism,
Hemicentin is required for proper attachment of cells to the
epidermis and for basement membrane organisation in the gonads
[27,28]. Whole mount in situ hybridisations revealed that
zebrafish hmcn1 was expressed in the apical median fin fold
epithelium from 20 hpf onwards (Figure 8E–8G), similar to the
expression patterns of fras1 and frem2a. Consistent with a role in fin
fold development, injection of a translation-blocking hmcn1 MO
generated embryos with fin blisters, resembling nel mutants
(Figure 8B and 8C). Furthermore, we found nonsense mutations
in the hmcn1 coding region of both sequenced nel alleles
(Figure 8H). The nel
tq207 allele displayed a 4545C.G substitution,
which leads to a premature termination of Hmcn1 after 1514 of
5616 amino acid residues, whilst the nel
fr22 allele contained a
nonsense mutation and an adjacent splice donor site-creating
mutation, both of which cause a C-terminal truncation of Hmcn1
after half of the protein (for details, see Figure S6A, S6B, S6C,
S6D, S6E, S6F, and S6G). Together, these data indicate that the
fin blistering of nel mutants is caused by loss-of-function mutations
in the hmcn1 gene.
We also identified zebrafish hmcn2 (Genbank accession numbers
GU936667 and GU936668), a second hemicentin paralogue also
present in mammals [29]. In contrast to the restricted expression
of hmcn1 in epithelial cells of the apical fin fold, hmcn2 transcripts
were present both in the fin fold epithelium and the fin
mesenchyme at 24 hpf (Figure 8I), and restricted to the fin
mesenchyme at 48 hpf (Figure 8J and 8K). However, neither a
translation-blocking, nor a splicing-blocking hmcn2 MO yielded a
consistent phenotype alone, nor did the hmcn2 MO clearly
enhance the nel phenotype (data not shown). This leaves the role
of Hmcn2 during zebrafish development currently unclear.
Hemicentin1 synergistically interacts with Fibrillin-2 and
Fras1, but not with Laminina5
During a morpholino screen of genes up-regulated in muscle
fibres, we observed fin blistering in embryos injected with an MO
against fibrillin2 (fbn2), similar to that of fras1 and hmcn1 mutants
(Figure 8L and 8M). Indeed this was confirmed by the recent
report of a zebrafish fibrillin2 mutant, puff daddy (pfd
gw1), isolated in
an ENU screen and characterised by defects in notochord and
vascular morphogenesis, but also displaying blistering of the fin
fold [18]. Furthermore, like fras1 and hmcn1, fbn2 displayed
expression in the median fin fold epithelium (Figure 8N). Fibrillin-
1 has been shown to directly interact with members of the Fibulin
protein family [30,31]. Given the similarity of phenotype, we
hypothesised that Hmcn1 (also called Fibulin-6) and Fbn2 might
similarly interact during zebrafish fin development in vivo, and
carried out synergistic enhancement studies, as described above for
fras1 and frem2a. Indeed, while individually, neither the hmcn1 nor
the fbn2 MO elicited a phenotype at low doses, when combined,
they generated fin blisters as in hmcn1 mutants (Figure S3I, S3J,
S3K, and S3L; Table 4). Thus Fibrillin2 and Hemicentin1 appear
to act in concert to maintain fin fold structure. Curiously, injection
of strong doses of fbn2 MO into nel
tq207/tq207 mutants realised
embryos with fin blistering much stronger than in either nel
mutants or strong fbn2 morphants alone (Figure S3AC, S3AD, and
S3AF). However, resulting embryos were indistinguishable from pif
mutants or frem2a/2b/3 triple morphants (Figure S3Y, S3Z, S3AA,
and S3AB). This suggests Hmcn1 and Fbn2 can partially
compensate for each other and highlights the complex interplay
of ECM molecules maintaining fin fold integrity.
The synergistic interaction between Fras1 and Frem2 on one
side and Hmcn1 and Fbn2 on the other side is consistent with
previous biochemical reports on these or other family members.
To investigate whether the two ECM complexes also cooperate
with each other, which has not been reported as yet, we next
carried out synergistic interaction studies between Hmcn1 and
Frem2a/Fras1. To study embryos completely lacking both Hmcn1
and Fras1 function, we generated pif
te262/te262; nel
tq207/tq207 double
mutants. Double mutants were as strong as pif single mutants
(Figure S3U, S3V, and S3X). However, combined partial loss of
Hmcn1 and Fras1 had a synergistically enhancing effect (Figure
S3M, S3N, S3O, and S3P; Table 5), similar to the effect between
Fras1 and Frem2a (Figure S3E, S3F, S3G, and S3H; Table 2). In
contrast, combined injections of sub-phenotypic doses of hmcn1
and lama5 MOs, although effective in dose-dependent interaction
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blistering or dysmorphic fins (Figure S3Q, S3R, S3S, and S3T;
Table 6). Together, this points to a common role of Fras1/
Frem2a/Hmcn1/Fbl2 in the basement membrane of developing
fin folds, which is distinct from that of Lama5/Itga3 complexes.
Fin blistering of fras1 and hmcn1 mutants occurs at the
level of the sublamina densa
In mouse Fras1 and Frem mutants, embryonic skin blistering
occurs at the level of the sublamina densa of the basement
membrane, with the BM remaining attached to the basal cell
Figure 8. The fin blistering of nagel mutants is due to mutations in the hemicentin1 gene. (A–C) Lateral views of the posterior medial tail fin
of WT larvae at 48 hpf injected with a morpholino targeting the translation site of hmcn1 mRNA (C). Blisters reminiscent of nagel mutant embryos (B)
are clearly visible compared to age-matched uninjected controls (A). (D) Genetic map showing the location of the nagel locus on LG20, which did not
recombine with the SSLP marker z35375. The genes within the interval, including hmcn1 (red arrow), are shown below. (E–G) Lateral views (E,F) and
transverse section (G) of embryos stained by in situ hybridisation with an hmcn1 probe, showing expression in somites (F) and in the apical region of
the fin fold at 16 hpf (E), 24 hpf (F), and at 48 hpf (G). (H) The zebrafish Hmcn1 protein is 5616 amino acids in length and contains a signal peptide
(pink bar), a Von Willebrand factorA domain (blue box), 44 Ig-like domains (brown diamonds), six thrombospondin type-1 repeats (red ovals), a
nidogen G2 domain (green triangle), five EGF-like domains (yellow bars) and a Neuralized homology repeat domain (orange bar). Mutations of the
two sequenced nagel alleles and their relative locations are indicated. (I–K) Lateral views (I,J) and transverse section (K) of embryos stained by in situ
hybridisation showing expression of hmcn2 in the tail region of the zebrafish embryo at 24 hpf (I) and 48 hpf (J,K). While at 24 hpf, hmcn2 is expressed
in the fin fold epidermis and the somites, (I), it becomes confined to fin mesenchyme cells at 48 hpf (J,K). probe Lateral view of a 48 hpf embryo
injected with fibrillin2 MO, showing strong blistering of the medial fin (M) compared to uninjected control (L). (N) Lateral view showing expression of
fbn2 in the medial fin fold of the tail at 24 hpf as well as in floor plate, hypochord and notochord.
doi:10.1371/journal.pgen.1000907.g008
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electron microscopy studies revealed that the same is true for
the median fin blisters of the zebrafish pif (fras1)a n dnel (hmcn1)
mutants, with the blister cavity forming below the lamina densa,
at the interphase of the basement membrane and the underlying
dermis (Figure 9A–9C). This indicates that zebrafish and
mammalian Fras1 play comparable structural roles within
developing basement membranes anchorage within the embryo-
nic skin. Furthermore, it suggests that Fras1 and Hmcn1 most
likely act at the same sites within basement membranes, in line
with the aforementioned synergistic interaction between the two
genes.
Cell–cell adhesion is initially unaffected in blister mutants
Previous electron microscopy studies of zebrafish lama5 mutants
have indicated defects in both epidermis – basement membrane
association as well as in epidermal cell-cell adhesion [21]. We
analysed the electron micrographs to establish if cell-cell adhesion
was also affected in the pif
te262/te262 and nel
q207/tq207 blister mutants.
It appeared that at 30 hpf, cells in the epidermis of the fin
maintained good adhesion with neighbouring cells despite having
detached from the dermis (Figure 9D–9F). This is in line with the
stable nature of the blisters at this stage. However by 48 hpf, the
fin blisters are beginning to collapse as the fin fold grows, and the
fins show signs of dysmorphogenesis. Ultrastructurally, large
cavities can be seen between basal cells and between basal cells
and overlying enveloping layer (EVL) cells (Figure 9G, red arrows).
Thus, it appears that initially cell-cell contacts are not affected by
the blistering below the basement membrane, whereas later cell-
cell adhesion defects can be seen concomitant with the onset of
overall fin degeneration.
Hmcn1 does not affect the stability or distribution of
Fras1 protein
Mouse Fras1 and Frem2 proteins have been shown to physically
bind to and stabilise each other [23], possibly accounting for the
observed genetic synergism between fras1 and frem2a in zebrafish
described above. To study whether a similar biochemical
interaction might also apply to zebrafish Fras1 and Frem2
proteins, and whether Fras1 stability might in addition require
Hmcn1, accounting for the revealed genetic synergism between
fras1 and hmcn1, we performed Fras1 immunostainings in pif
mutants, frem2a/b/3 morphants and nel mutants. Whilst we
observed strong Fras1 immunostaining within the fin fold of
wild-type embryos at 32 hpf (Figure 9H), immunostaining was
absent both in pif
te262/te262 mutants (Figure 9I; compare with
Figure 7K and 7L) and in embryos deficient for frem2a, frem2b and
frem3 (Figure 9J), consistent with the reciprocal stabilisation of
these proteins. In contrast, we observed clear Fras1 immunostain-
ing, basal to the epidermal cells and at the lateral edges of both
nascent and older blisters of nel
tq207/tq207 mutants (Figure 9K and
9L). This demonstrates that in contrast to Frem2, Fras1
stabilisation does not require Hmcn1.
Discussion
Studying the processes involved in medial and paired fin
development of lower vertebrates has implications for understand-
ing the aetiology of human limb malformations [33,34]. There are
a large number of syndromic limb malformations reported
[reviewed in 35]. Included in these is Fraser Syndrome, which
presents a broad range of defects including cutaneous syndactyly
of the limbs. Based on analysis of the mouse ‘bleb’ mutants which
model Fraser syndrome, this syndactyly is hypothesised to be a
Table 4. Synergistic interaction between fbn2 and hmcn1.
uninjected control fbn2 ATG MO 1:40 hmcn1 ATG MO 1:20
fbn2 ATG MO 1:40 + hmcn1
ATG MO 1:20
CSCSCSCS
WT fin (%) 100 100 44 97 96 100 49 46
single blister (%) 00032021 3
multiple blisters (%) 0000004 9 4 1
degenerate fins (%) 00002000
n 5 98 44 47 44 76 23 97 4
For more information see Table 1.
doi:10.1371/journal.pgen.1000907.t004
Table 5. Synergistic interaction between fras1 and hmcn1.
uninjected control fras1 ATG MO 1:10 hmcn1 ATG MO 1:20
fras1 ATG MO 1:10 +
hmcn1 ATG MO 1:20
CSCSCSCS
WT fin (%) 47 127 46 151 90 100 36 59
single blister (%) 0000602 1 8
multiple blisters (%) 0010404 1 3 2
degenerate fins (%) 00000021
n 47 127 47 151 49 111 104 121
For more information see Table 1.
doi:10.1371/journal.pgen.1000907.t005
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uninjected control lama5 splice MO 1:80 hmcn1 ATG MO 1:20
lama5 splice MO 1:80 + hmcn1
ATG MO 1:20
CSCSCSCS
WT fin (%) 100 100 100 99 91 100 98 100
single blister (%) 0 0 0 0 7 0 2 0
multiple blisters (%) 0 0 0 0 2 0 0 0
degenerate fins (%) 0 0 0 1 0 0 0 0
n 42 143 51 117 45 113 49 161
For more information see Table 1.
doi:10.1371/journal.pgen.1000907.t006
Figure 9. fras1 and hmcn1 mutants display blister formation at identical sites below the basement membrane; however, in contrast
to Frem2/3 proteins, Hmcn1 is dispensable for Fras1 stabilisation. (A–C) Electron micrographs of the sub-epidermal space of medial fin folds
at 30 hpf in WT (A), pif
te262/te262 (B), and nel
tq207/tq207 (C) embryos. Epidermal cells (indicated by ‘ep’ in A) are at the top of all panels as well as in the
lower part of A. The lamina densa of the basement membrane (labelled with ‘bm’ in A), including the sublamina densa, is attached to the epidermal
cells in all three panels. Below the bm, electron dense material is evident as actinotrichia (ac) or dermis material (de), which appears disorganized and
in the two mutants (B,C). (D–G) Low power electron micrographs of the apical portion of the fin fold in WT (D), pif
te262/te262 (E), and nel
tq207/tq207 (F–G)
embryos at 30 hpf (D–F) and 48 hpf (G). Cell–cell adhesion is well preserved in both mutants at 30 hpf (E–F), but at 48 hpf, when the blister begins to
collapse, cell-cell boundaries become compromised (G, red arrows). The basal and outer enveloping layers are indicated with yellow and green bars
respectively. (H–L) Transverse sections fluorescently immunostained for Fras1 (green), epidermal p63 (red) and counterstained with DAPI (blue) at3 0
hpf (H–K) and 48 hpf (L). Fras1 immunoreactivity is evident between the fin folds in WT embryos (H), but lost in pif
te262/te262 mutants (I) as well as in
embryos injected with MOs against frem2a, frem2b, and frem3 (J). In contrast, it is retained in nel
tq207/tq207 embryos at both 30 hpf (K) and 48 hpf (L),
when blistering is even more severe.
doi:10.1371/journal.pgen.1000907.g009
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developing limbs. Two of the disease genes underlying Fraser
Syndrome in humans were identified as FRAS1 or FREM2, which
encode structurally related basement membrane proteins. Muta-
tions in FRAS1 or FREM2 were found in approximately 50% of
investigated cases of Fraser Syndrome, whereas the molecular
lesions underlying the other half remain unknown.
The known bleb mutant genes Fras1, Frem1/2, and Grip1/
2 have conserved roles in zebrafish
We have cloned zebrafish mutants with embryonic blistering of
both the medial fin fold and the paired fins. Two of the loci, pinfin
(pif) and blasen (bla), map to and have lesions in the fras1 and frem2a
genes, thus demonstrating that these mutants represent zebrafish
models of Fraser Syndrome. We have further confirmed this by
reproducing the phenotypes by antisense morpholino knockdown
of these genes, however, due to the large size of their genes and
mRNAs, rescue experiments with either BACs or in vitro
synthesized mRNAs were impossible. Nonetheless our data clearly
demonstrate that mutations in Fras1 and Frem2 related proteins in
zebrafish yield blistering of the apical ectodermal ridges analogous
to that occurring in mammalian mutants for these genes. Similar
blistering is seen the zebrafish rafels mutants, which we have
identified as harbouring mutations in the frem1a gene, an
orthologue of mouse Frem1. Mouse Frem1 mutants (head blebs)
also belong to the ‘bleb’ class of mutants, exhibiting embryonic
blistering of the extremities although with background variability.
Whilst the phenotype of rafels further extends the homology of the
role of the Fraser complex proteins in AER morphogenesis, it is
noteworthy that a recent report has described human patients
bearing FREM1 mutations which display bifid nose and anorectal
malformations but not the classic Fraser syndactyly, cryptophthal-
mos or ablepharon, although they do show renal agenesis similar
to the Fraser syndrome patients [36]. This highlights the proposal
that Frem1 plays a slightly different function to Fras1/Frem2,
contrasting the largely indistinguishable phenotypes obtained
upon loss of Fras1, Frem2 or Frem1 function in mouse and
zebrafish.
In zebrafish, we found frem1a to display a partially redundant
role with its paralogue frem1b, and frem2b to display a partially
redundant role with frem2b and frem3. Whilst it appears that both
frem2b and frem3 are expressed, to varying extents, in the fin folds
at some stage, only loss of Frem2b generated strong fin blistering
when injected alone, presenting mostly in the blood island region
of the ventral medial fin. Interestingly this site is largely unaffected
in the frem2a mutant embryos, suggesting regional sub-functiona-
lisation of the Frem2 role between the two paralogues. Finally, we
show that antisense knockdown of frem3, which does not generate a
phenotype by itself, strongly enhanced the fin blistering of frem2a
mutants (or morphants), whereas it had no effect in the frem2b
morphant or fras1 mutant background. We also noted that the loss
of both Frem2 proteins and Frem3 resulted in blistering of the
same severity as pif (fras1) mutants. Together, this indicates partial
functional redundancy between Frem2 and Frem3 proteins.
Indeed, zebrafish Frem3 appears to have identical domain
structure to the Frem2 proteins. This is the first loss-of-function
analysis for Frem3 in any organism, since in contrast to Frem1 and
2, no mouse Frem3 mutant has been reported as yet.
One further family of genes contributing to the Fraser protein
complex, are the intracellular PDZ domain containing proteins
Grip1 and Grip2. These have both been shown to interact with
the conserved C-terminal residues of Frem2 and Fras1 and localise
them correctly to the basal side of the epidermal cell, from where
they can be secreted into the basement membrane [9]. We have
shown that zebrafish grip1 is expressed in an overlapping fashion to
the fras/frem genes and that depleting the protein levels of both
grip1 and the maternally and ubiquitously expressed grip2, realised
strong fin blistering. Thus we have demonstrated that all known
genes contributing to the human Fraser Syndrome or the mouse
‘bleb’ phenotype generate fin blisters in the zebrafish and conclude
that the zebrafish is a valid model for Fraser Syndrome.
Fraser syndrome is a complex disease and presents with multiple
pleiotropic defects, all of which seem to derive from spatially
restricted and transient basement membrane disruption. Aside
from the limb abnormalities, patients sometimes also display renal
agenesis, craniofacial dysmorphism, and cryptophthalmos or
ablepharon, however there are numerous other defects reported.
There is significant clinical variability and no single phenotype is
always present [1]. Of the other major diagnostic criteria of Fraser
Syndrome, we have only noted craniofacial defect (unpublished
data). Intriguingly we have not found any evidence of renal cysts
or malformations, which, however, may be due to a lack of
ureteric branching in zebrafish – the kidney of zebrafish larvae
consists of a single nephron.
Fras1 and Frem2 might be released from the cell surface
via proteolytic cleavage by Furin proprotein convertases
Fras1 and Frem2 contain a C-terminal transmembrane domain.
However, according to recent data obtained in cell culture studies,
they can be shed from the cell surface. The proteases mediating
such ectodomain shedding remained unidentified [23]. Here, we
provide both genetic and biochemical evidence that in zebrafish,
the proprotein convertase FurinA is involved, and that Furin-
mediated ectodomain shedding is important for proper function of
Fras1 and/or Frem2 within the fin fold basement membrane
(Figure 7). As direct in vivo evidence for this notion, we have
studied the localisation behaviour of Fras1 protein in chimeric
embryos and in the presence or absence of FurinA (Figure 7K and
7L). We observed that in a wild-type environment, Fras1 protein
can indeed be found in the basement membrane distant from its
source cell, showing that it does not remain membrane tethered in
vivo. Rather, it seems to be shed, allowing the protein to move
relative to the overlying cell. By mechanisms we do not fully
understand as yet, but which might involve the observed higher
proliferation rates of epidermal cells in proximal positions of the
forming fins (Figure 7Q and 7R), this Fras1 displacement seems to
be directed, occurring in a distal-to-proximal direction only, but
not vice versa. Critically, we were able to show that FurinA is
required for this Fras1 displacement, as Fras1 was retained on the
baso-lateral surface of transplanted furinA (stu) mutant cells. This
also shows that FurinA fulfils it indispensable sheddase role in a
cell-autonomous manner within the Fras1-generating cells itself.
This is consistent with recent results, demonstrating Furin-
mediated shedding of transmembrane collagens like Collagen
XXIII in the Golgi network, but not at the cell surface, of cultured
keratinocytes [37].
We noted, however, that the blistering seen in sturgeon (stu; furina)
mutants was less penetrant than in the pinfin or blasen mutants.
Additionally, failed Fras1 protein displacement was only observed
for stu mutant cells in rather posterior positions of the median fin,
but not in more anterior positions (data not shown), consistent with
the location of the blisters in stu mutants. We attribute this to
regional-specific differential redundancy of FurinA with other
Fras1 sheddases, or to regional- or temporal-specific compensation
by maternally supplied furina transcripts, which are not affected in
sturgeon mutants. We attempted to fully abolish maternal
compensation by use of a morpholino against the translation start
site of furina, however, this generated strongly dorsalised cells or
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lished observations), presumably due to failed processing of Bone
Morphogenetic Proteins (BMPs), known targets of Furins which
are implicated in early dorsoventral patterning of the zebrafish
embryo [38]. The presence of a second furin orthologue in the
zebrafish (furinb) combined with yet other related proprotein
convertases, might also partly compensate for the loss of
zygotically generated FurinA protein in sturgeon mutants. In
reverse, FurinA might have other target proteins in addition to
Fras1 and Frem2. Thus, we also noted mildly compromised fin
morphogenesis and a ruffled appearance of the fins of sturgeon
mutants. This is likely to be the result of failed processing of other
known targets of Furin involved in fin morphogenesis, such as
Itga3 [39] and collagens [37]. In conclusion, our data point to a
novel role of a Furin proprotein convertase in fin development and
the formation of a functional Fraser complex to allow proper
basement membrane anchorage.
Hemicentins, Fibrillin2, and the Fraser complex
The third fin blistering locus we positionally cloned was nagel
(nel), which we found to encode Hemicentin1 (Hmcn1), like Fras1
and the Frem proteins another potential basement membrane
protein (Figure 8). As nel represented one of the highest hit loci in
the original Tubingen mutagenesis screen [40], we reasoned that
the gene was likely to encode either a very large protein or a very
well conserved protein (thus sensitive to substitution mutations),
both of which is the case. While nothing was known about
Hemicentin1 function in vertebrates, the C. elegans orthologue has
been shown to be involved in organising epithelia attachment [27].
We identified two hmcn1 nonsense mutations in nel alleles and thus
describe the first hemicentin mutant in a vertebrate species. We
further showed that whilst hmcn1 and fras1 synergistically interact
in the fin fold, the presence of Fras1 protein was unaffected in nel
mutants. This is in contrast to the indispensable effect of Frem2 on
Fras1 stability (Figure 9), consistent with the reciprocal stabilisa-
tion of mammalian Fras/Frem proteins in the basement
membrane [23]. In conclusion, in contrast to Frem proteins,
Hmcn1 does not seem to be required for Fras1 stability. Hmcn1
antibodies need to be raised to investigate whether conversly,
Fras1 is also dispensable for Hmcn1 stability. In C. elegans,
Hemicentin is associated with hemidesmosome-type structures,
mediating attachment between epithelial cells and the underlying
basement membrane. However this is not necessarily true in
zebrafish, which does not generate visible hemidesmosomes until
3dpf [41], well after the first observable nagel phenotype. Rather,
according to our EM studies, Hmcn1 is required for proper
attachment of the basement membrane to the underlying dermal
compartment. Furthermore, the phenotypes of nel and pif mutants
at both the morphological and ultrastructural level, combined with
the synergistic interaction studies, strongly points to a previously
unrecognised requirement for Hmcn1 in generating a fully
functional Fraser complex.
Curiously, unlike the nonsense fras1 alleles, which die between
11–12 dpf, the hmcn1 alleles are adult viable and do not display any
overt phenotype, pointing to differential dependence of the Fraser
complex on Hmcn1 in different organ contexts. The reason for the
larval death of strong pif mutants is currently unclear, however the
mutant larvae fail to inflate a swim bladder, and remain at the
bottom of the tanks lying on their sides, unable to feed. We have
shown that in addition to the fin folds, fras1 is expressed in the
brain (midbrain-hindbrain boundary/cerebellum), the ear and the
craniofacial system. In addition to the fin blistering, pif mutants
display subtle craniofacial defects (J. Coffin Talbot et al.,
unpublished data), and we propose that the observed compro-
mised swimming behaviour of mutants might be due to
neurological and balance defects, altogether resembling the
craniofacial, ear and neurological phenotypes that are diagnostic
criteria for human Fraser syndrome [1]. However, more detailed
investigation beyond the scope of this work is required to fully
understand these later phenotypic traits.
For the embryonic fin blistering mutants that survive, we noted
that generally there is no overt adult fin phenotype, with the
exception of the pif
tm95b mutants. There could be two explanations
for this. Firstly, during later developmental stages, the described
partial functional redundancy, e.g. between frem1a/1b, or between
frem2a/2b/3 might become even more prominent. Indeed, most of
them are co-expressed in adult fins (data not shown). Alternatively,
as demonstrated in the mouse, the Fraser complex in its entirety
might only have a transient requirement during embryogenesis,
whereas later, its function in tethering the BM to the underlying
dermis is taken over by Collagen VII [12]. Of all viable blistering
mutants, only the weak fras1 allele, pif
tm95b, showed a reduced and
mis-patterned adult fin. Whilst this could reflect the lack of a
paralogous gene to compensate for its function (the zebrafish
genome appears to contain only one fras1 gene), it may also be due
the dominant nature of this mutation, with potential disruption to
other basement membrane or dermal components during adult fin
morphogenesis. Identification and analysis of other mild viable pif
alleles should help to resolve this point.
hemicentin2 (hmcn2) is also expressed in the fin fold during
embryogenesis, however, mostly in the fin mesenchyme. The role
of this cell population during fin morphogenesis is presently
unknown and we sought to determine the function of hmcn2
through morpholino knockdown. However, injection of a transla-
tion-blocking MO led to no observable fin phenotype, even when
injected into hmcn1 mutants, leaving the function of Hmcn2
unclear.
The Hemicentins belong to the Fibulin family of proteins,
characterized by the presence of a C-terminal Fibulin domain.
Other members of the Fibulin family (2,4,5) are known to directly
bind Fibrillin-1, which is involved in elastic microfibril formation
[30]. We found zebrafish fibrillin2 (fbn2) to be co-expressed with
hmcn1 and the fras1/frem2 genes in the apical fin fold epidermis,
while morpholino-based fbn2 knockdown generated fin blistering
phenotype comparable to that of nel and pif mutants (Figure 8).
This phenotype has been confirmed in the fbn2 mutant puff daddy
[18]. Furthermore, we could demonstrate a dose-dependent
interaction between zebrafish Hmcn1 (also known as Fibulin-6;
see above) and Fbn2, thereby extending the known associations
between Fibrillins and Fibulin-type proteins, and revealing that
Hmcn1 and Fbn2 cooperate to mediate epidermis-basement
membrane and/or basement membrane-dermis attachment in
vivo. One implication from our work is that the Fraser complex is
linked to fibrillin-containing microfibrils within the dermis via
Hemicentin1. We are currently applying biochemical approaches
to test this notion.
Consistent with an involvement of Fbn2 in Fraser complex
function, Fbn2-deficient mice display limb defects ranging from
cutaneous to skeletal syndactyly, reminiscent of the ‘bleb’ mutant
mice [42]. The embryonic phenotype in Fbn2
2/2 null mice has
not been reported, however, it is tempting to predict that there
may be transient distal limb blistering.
For the future, it will be interesting to characterise the function
of Hemicentins in mammals, in particular generating and
analyzing mouse mutants lacking Hmcn1 and/or Hmcn2.
Furthermore, given the similarity of phenotypes between zebrafish
fras1, hmcn1 mutants and fbn2 mutants, coupled with the lack of
mutations in any of the FRAS1/FREM/GRIP genes in approxi-
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be strong candidate genes mutated in these patients. Other
candidates emerging from our work are Furin proprotein
convertases.
Itga3 and Lama5 are primarily required for epidermis-BM
attachment; Fras1, Frem, and Hmcn1 for BM-dermis
attachment and possibly BM elasticity
In addition to mutants displaying blistering of the fins, we also
described a second class of mutants displaying globally compro-
mised fin morphogenesis. One of them, fransen, is caused by a
mutation in the Laminina5, a subunit of Laminin511, which like
Fras1/Frem2 proteins and Hmcn1 is integral part of the basement
membrane (BM). The other, badfin, is caused by a mutation in
Integrina3, which is part of the a3b1 Integrin dimer, the receptor
for Laminin511 and other BM proteins on epidermal cells.
Similarly, Frem1 has been shown to mediate cellular adhesion in
vitro through interactions with a5 and a8-containing integrin
receptors [43]. We can only speculate about the molecular basis of
the different phenotypes of fras1/frem/hmcn1 (fin blistering) versus
lama5/itga5 mutants (compromised fin morphogenesis). Recent
studies of another lama5 allele have revealed defects in epidermal
integrity of the fins, including compromised epidermal cell-cell
adhesion and compromised attachment of the epidermis in the
underlying BM [21]. In contrast, we could show here by electron
microscopy that cell-cell adhesion and cell-BM attachment
remains intact in the fras1 and hmcn1 fin blister mutants. This
suggests that Lama5 and Fras1/Frem/Hmcn1 are required in
different layers of the BM, with Lama5 primarily involved with
epidermis-BM attachment via an Integrina3 containing receptor,
whereas Fras1/Frem2/Hmcn1 acting in deeper positions below
the BM, mediating BM-dermis attachment. The retention of the
BM to the cell surface in the fin blistering mutants has important
implications for the cells. As Laminin activation of Integrins still
occurs, we could expect Integrin-mediated outside-in signalling to
persist. One such known intracellular effect downstream of
Integrina3 signals is the assembly of adherens junctions, which
are crucial for proper cell-cell adhesion [44]. Thus the critical
difference between the fras1/frem/hmcn1 mutants and the itga3/
lama5 mutants is the maintenance of Integrin-mediated signalling
via basement membrane components on the basal side of
epidermal cells in the blistering mutants, promoting persistent
strong cell-cell adhesion through adherens junction at the lateral
sides of the cells (summarised in Figure 10). It is also noteworthy
that in contrast to many Laminins and Collagens, the proteins of
the Fras1/Frem2 complex as well as Hmcn1 and Fbn2 are no
constitutive BM components. Rather, their occurrence is restricted
to particular embryonic sites and developmental stages, such as the
apical fin folds during fin morphogenesis. According to our EM
analyses, basement membranes at this site and stage are just
beginning to become morphologically distinct, suggesting that
Fras1/Frem2/Hmcn1/Fbn2 might be specifically required during
basement membrane formation. In addition or alternatively, they
might confer specific properties such as elasticity to basement
membranes that are under high mechanical stress or in the process
of spatial rearrangements, as during fin or limb outgrowth. This
would also be in line with the formerly described attachment of
Fibulins and Fibrillins to elastic fibers [45,46,47].
Materials and Methods
Fish lines
Embryos were obtained through natural crosses and staged
according to [48]. The mutant alleles pif
te262, pif
tm95, nel
tq207, bla
ta90,
fra
tc17, rfl
tc280b, rfl
tr240, bdf
tz296 and stu
td204e were obtained from the
Tu ¨bingen stock centre and have been previously described
[13,26], whilst the alleles bdf
fr21, nel
fr22 and rfl
fr23 were isolated in
a recent ENU mutagenesis screen conducted in the Hammersch-
midt laboratory in Freiburg. pif
b1048 and pif
b1130 were isolated in
another recent ENU mutagenesis screen conducted in the Kimmel
laboratory. Meitoic mapping was performed by crossing hetero-
zygous adults to the wild-type WIK strain to generate hybrid F1
mapping fish.
Genetic mapping
Genetic mapping was performed largely as per [49]. Hetero-
zygous F1 carriers from WIK out-crosses were in-crossed and
pools of either mutant or sibling F2 progeny were subjected to bulk
segregation single sequence linkage polymorphism (SSLP) analysis.
Upon assignment to a linkage group, fine SSLP mapping on single
arrayed mutant embryos was used to confirm linkage and generate
a broad interval on the genome. Candidate genes within this
interval were selected and tested for expression in the fin fold and
further analysis.
Microscopy
For imaging, live embryos were anesthetised with Tricaine and
mounted in 3% methyl cellulose, whilst embryos stained by in situ
hybridisation or antibody staining were cleared in glycerol prior to
mounting. Fluorescent images were taken with a Zeiss Confocal
microscope (LSM710 META); bright-field or Nomarski micro-
scopy was performed on a Zeiss Axioimager. Transmission
electron microscopy was carried out as previously described [50].
In situ hybridisations and probe synthesis
Embryos were fixed in 4% PFA in PBS overnight at 4uC and in
situ hybridisations were performed as previously described [51],
using probes generated from cloned cDNA fragments of fras1,
frem2a, frem2b, frem3, frem1a, frem1b, grip1, grip2, hmcn1, hmcn2, furina,
fibrillin2 and itga3. Probes were synthesised from linearised
plasmids using the Roche digoxygenin RNA synthesis kit.
Antibody generation, immunohistochemistry, and
sectioning
An antibody against zebrafish Fras1 was generated by cloning
the cDNA region encoding amino acids A1210 to H1525 of the
Fras1 protein (predicted size: 34.5 kDa) into the prokaryotic
expression vector pGEX-2TK-P (GE Heathcare) containing a
glutathione S-transferase (GST) tag. This fragment corresponds to
that used by Vrontou et al. to generate a specific antibody against
mouse Fras1 [4]. Recombinant protein was expressed in E. coli
BL21 cells, purified via glutathione affinity chromatography, and
used to immunise rabbits (Pineda Antiko ¨rper Service, Berlin,
Germany). Obtained sera were tested for immunogenicity by
western blot and ELISA analysis. Immunoreactive sera were
affinity-purified against the same recombinant Fras1 fragment
used for immunization, coupled to CNBr-activated sepharose.
Whole mount fluorescent antibody stainings were performed as
described [51]. Antibodies and dilutions used were as follows:
rabbit anti-zebrafish Fras1 (1:100); 4A4 anti-p63 (1:200, Santa
Cruz), chicken anti-GFP (1:200, Invitrogen), AlexaFluor546 goat
anti-mouse (1:400, Invitrogen), AlexaFluor488 goat anti-rabbit
(1:400, Invitrogen) and AlexaFluor 647 goat anti-chicken (1:200).
For sectioning, double- or triple-immunostained (Fras1, p63,
GFP) embryos were counterstained with DAPI to visualise the
nuclear DNA, mounted in Durcupan ACM (Fluka Chemicals), cut
into 7 mm sections, and analyzed via confocal microscopy.
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RT–PCR, and 59RACE
Genomic DNA from adult fin or embryos was extracted by
incubation of the tissue in lysis buffer for at least 4 hours at 55uC.
Extracted DNA was diluted ten-fold before PCR analysis. Total
RNA was isolated from embryos using Trizol-LS (Invitrogen, CA)
and cDNA synthesized with SuperscriptII reverse transcriptase
(Invitrogen). Sequences corresponding to zebrafish orthologues of
fras1, frem2a, hmcn1, lama5 and itga3 were obtained from the
zebrafish genome (Ensembl, Sanger Center), and amplified via
Figure 10. Model describing the ultrastructural changes underlying the fin phenotypes of blistering and dysmorphogenesis
mutants. (A) A simplified model depicting epidermis–basement membrane (BM) and dermis attachments in wild-type embryo. A transverse section
through a fin shows basal epidermal cells (grey boxes) attached via Integrin heterodimeric receptors (IR, light and dark brown lines) to the underlying
BM (dark green lines) containing Laminina5. Below this lies the Fraser complex (FC, indicated by a red bracket) containing Fras1, Frem2(a/b)/3, and
Frem1(a/b). This attaches the BM to the underlying dermis (D, grey grid) possibly via a complex including Hemicentin1 (H, indicated with an orange
arrow). Cell–cell adhesion between epidermal cells is maintained through adherens junctions (AJ, light blue lollipops), which assemble and are
stabilised via Integrin receptor signalling from the basal side (grey dashed arrows). (B) Loss of any component of the Fraser complex or Hemicentin1
abrogates attachment of the BM to the underlying dermis. However, Integrin-mediated cell attachment of epidermal cells to the BM is not
compromised, and Integrin-signalling continues to maintain adherens junctions and high cell–cell adhesion among epidermal cells. As a
consequence, the fin fold lifts away from the underlying dermis as an intact epidermal sheet, causing blistering. (C) Loss of the Integrin receptor in
epidermal cells or its ligand (Laminin) in the basement membrane leads to compromised epidermal–BM attachment, and to reduced Integrin
signalling within epidermal cells, thereby also compromising intracellular Integrin signalling, adherens junctions and epidermal cell-cell adhesion). As
a result, the integrity of the epidermal sheet is disrupted, and the sheets fail to undergo normal fin morphogenesis (compare with schematic shown
in Ref. 21).
doi:10.1371/journal.pgen.1000907.g010
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frem3, frem1a, frem1b, grip1, grip2, hmcn1 and hmcn2 cDNAs, 59RACE
was performed using the SMART RACE kit (BD Biosciences,
CA).
Morpholino (MO) injections
Morpholinos were ordered from Gene Tools (Philomath, OR)
and dissolved in distilled water to 1 mM stock solutions. For
injection, stocks were diluted in Danieau’s buffer and Phenol Red
as indicated in text, tables or figures [52]. 1.5 nl of MO solution
was injected into embryos at the 1–4 cell stage using glass needles
pulled on a Sutter needle puller and a Nanoject injection
apparatus (Word Precision Instruments). MOs used and their
sequences (given 59-39) were as follows:
fras1-ATG: ATAGGACCCATATTCACTTAAAAGC
fras1-splice: CTTTGGTGTGCTATAAAAAATTGAA
frem1a-ATG: CACATTTGCTGGTTTTTACAGTCAT
frem1a-splice: TATAATGTGATGCTTGTTACCCAGC
frem1b-ATG: GGAAGAAAACCCCCATCTTTTTGGC
frem1b-splice AGCAGATGCTGGTCATTTACATGTC
frem2a-ATG: GGAGAAGAAATCTGTGAAGTTCCAT
frem2b-ATG: GCTCTGTTCTACTCCCAGCCATTTG
frem2b-59UTR CATTTGTAATGTAAACAACAGTTAC
frem3-ATG: GCAGACAACCAGCCATATCTACAGC
frem3-splice AGATGATGGTCTCTGACCTGTGTCT
grip1-ATG: TGACAAAGCCAAGAAAGCGTTCCAT
grip1-splice AATGCGTCACTTGTACTGACCTAGC
grip2-ATG: CTCTCTCCTCAAACCACACAGCATC
grip2-59UTR ATCGTGGGAAAATCACGAATCCATT
hmcn1-ATG: AAAACGGCGAAGTTATCAAGTCCAT
hmcn2-ATG: TAACGACAAACTTTTTCATTCTCAC
hmcn2-splice: GTTGTGCTGATGTAGTAATACCTTT
lama5-splice: AACGCTTAGTTGGCACCTTGTTGGC
itga3-ATG: GTGCAGAGACTTTCCGGCCATATTT
itga3-splice AGTCAAATGCGCTAACTCACCCTGC
furina-ATG: TATAGGAGAACCAAGGCAGGAATT
fbn2-splice: AGTTTTATTGTGAACTCACCCACAC
Cell transplantations
For the analysis of Fras1 protein distribution behaviour in vivo
(Figure 7 K and 7L), chimeric embryos were generated by
injecting wild-type embryos with in vitro synthesised GFP mRNA,
or embryos from a clutch of two stu/+ parents with furina MO
(1:20 dilution of 1 mM stock) and GFP mRNA, followed by
homochronic and homotopic transplantation of ventral ectoder-
mal cells into the offspring of two pif
te262/+ parents at the shield
stage. Chimeric embryos were inspected for the pif phenotype and
for fluorescent fin epidermal cells at 26 hpf, and were processed via
immunostainings and sectioning as described above. In case of
donors from a stu/+ x stu/+ cross, donor embryos were genotyped
after the transplantation as previously described [19,26]. For cell
lineage analysis (Figure 7Q and 7R), similar transplantations were
carried out between Tg(bactin::hras-egfp) (vu119; [53]) donors and
wild-type hosts.
Fras1 and Frem2 ectodomain shedding assay
The assay was conducted as previously described [23]. Briefly,
293F cells were transfected with HA-tagged mouse Fras1, Myc-
tagged mouse Frem2 or empty expression vector, and incubated
for 6 hours. Then either DMSO or the Furin inhibitor Decanoyl-
RVKR-CMK (Calbiochem) was added to the cells to a final
concentration of 30 mM. After further incubation for 24 hours,
levels of protein shed into the medium were determined by
western immunoblotting of both cell lysates (as a reference) and
conditioned medium, using antibodies against the corresponding
tags. 293F cells are derivatives of HEK-293 cells, which are known
to express Furin endogenously [54,55].
Supporting Information
Figure S1 Zebrafish fin mutants can be classed in two
phenotypic groups. (A–X) Lateral Normarski images of the
mutants pinfin (B–C, J–K, R–S), blasen
ta90 (D, L, T), rafels
fr23
(E,M,U), nagel
tq207 (F, N, V), fransen
tc17 (G, O, W) and badfin
fr21 (H,
P, X) displaying medial fin defects compared to wild-type embryos
(A,I,Q). Embryos are shown at 32 hpf (A–H), 48 hpf (I–P) and 5
dpf (Q–X). Images of both a strong (pif
te262; B, J, R) and a weak
(pif
tm95; C, K, S) allele of pinfin are shown, which along with blasen,
rafels and nagel, all display blisters within the fin fold. In contrast
fransen and badfin mutants do not show blisters, rather dysmor-
phogenesis from 32 hpf onwards. Within the group of blister
mutants, there was a range of severity, such that the blisters of the
weak pinfin allele (pif
tm95) and the single blasen allele (bla
ta90) appear
quite small at 30 hpf and are only visible in some mutant embryos
at 48 hpf, whilst the blisters of the strongest pinfin allele (pif
te262) are
prominent at 30 hpf and always visible at 48 hpf. The blisters of
the rafels alleles are clear but only prominent in the posterior
medial fin at 48 hpf and not evident at 32 hpf. The extent of fin
fold degeneration is more severe at 5 dpf in the strong pinfin allele
than either the blasen or weak pinfin allele. All three nagel alleles
display large blisters covering much of the fin fold field, but rarely
affect the blood islands. Like the strong pinfin allele, these blisters
persist until 48 hpf at which point the fin begins to degenerate. (Y–
Z) Uniquely pif
tm95/+ heterozygous embryos display a mild fin
blister phenotype (Z-arrow) seen in either a lateral view (top panel)
or dorsal view (lower panel) and compared to a WT sibling (Y).
Found at: doi:10.1371/journal.pgen.1000907.s001 (4.37 MB TIF)
Figure S2 Pectoral and adult tail fin phenotypes. (A–I) Lateral
views of pectoral fins at 72 hpf showing the blisters (red arrows)
present inpif
te262/te262(B),pif
tm95/ttm95 (C),bla
ta90/ta90 (D),nel
tq207/tq207
(E), stu
td204/td204 (F) and rfl
fr23/fr23 (G) embryos compared to WT (A).
The dysmorphogenesis of the pectoral pins in fra
tc17/tc17 (H) and
bdf
fr21/fr21 (I) is highlighted with the edge of the fin circumscribed
by red dashed line, clearly showing the reduction of the fin
compared to WT (A). (J–O) Adult fin phenotypes at 96 dpf: the
tail fins of pif
tm95/ttm95 (K) and bdf
fr21/fr21 (O) mutants are reduced
compared to WT (J), bla
ta90/ta90 (L), nel
tq207/tq207 (M) and rfl
fr23/fr23
(N).
Found at: doi:10.1371/journal.pgen.1000907.s002 (3.46 MB TIF)
Figure S3 Synergistic interaction and compound mutant/
morphant analyses. (A–T) Demonstration of synergistic interac-
tions between itga3 and lama5 (A–D), fras1 and frem2a (E–H), hmcn1
and fbn2 (I–L), and fras1 and hmcn1 (M–P), but not hmcn1 and lama5
(Q–T). Images show lateral views of embryos tails at 30 hpf (I–L),
36 hpf (E–H) or 48 hpf (A–D; M–T) after injection of sub-
phenotypic doses of morpholinos against itga3 (B), fras1 (F,N),
frem2a (G), hmcn1 (J,O,S), fbn2 (K) or lama5 (C,R). All single
morphants appear as their uninjected WT controls (A,E,I,M,Q).
In contrast, a dysmorphogenic phenotype is seen upon itga3 and
lama5 co-injection (D), whilst blisters are evident upon combined
injection of fras1 and frem2a (H), hmcn1 and fbn2 (L) and fras1 and
hmcn1 (P). Neither phenotype is seen upon co-injection of hmcn1
and lama5 (T). (U-X) Lateral views of the medial fins of pif
te262/te262
(V), nel
tq207/tq207 (W), pif
+/te262; nel
+/tq207 (U) and pif
te262/te262;
nel
tq207/tq207 (X) embryos at 30 hpf, showing that blisters in the
double mutant are more severe than in nel
tq207/tq207, but of equal
severity to pif
te262/te262. (Y-AB) Lateral views on tails of embryos at
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2b/3 combined with loss of fras1 (AB) appears as severe as loss of
either fras1 alone (Z) or combined loss of frem2a/2b/3 (AA). WT
embryo is shown for comparison (Y). (AC-AF) Additive function of
hmcn1 and fbn2 as assessed by generation of compound mutant/
strong morphant embryos imaged at 32 hpf. Injection of strong
doses of fbn2 MO into nel
tq207/tq207 (AF) generated embryos with
stronger blistering than nel
tq207/tq207 (AD) or strong fbn2 morphants
(AE) alone.
Found at: doi:10.1371/journal.pgen.1000907.s003 (4.53 MB TIF)
Figure S4 Confirmation of morphant phenotypes with second
morpholino. Injection of second non-overlapping morpholinos was
used to verify morphant phenotypes. Injection of translation-
blocking morpholinos against fras1 (A), frem1a (B) and frem2b (D)
into WT embryos realised blisters in the fin fold comparable to
those seen with the original morpholinos. The fin blister
phenotypes of rafels (C) and blasen (E) could be enhanced by the
injection of morpholinos targeting the frem1b 59UTR and frem3
ATG respectively. Co-injection of grip1 ATG and grip2 59UTR
morpholinos also yield strong blistering of the fin fold identical to
that obtained with the original MOs (F).
Found at: doi:10.1371/journal.pgen.1000907.s004 (1.88 MB TIF)
Figure S5 Fras1 distribution is compromised in sturgeon mutant
fins. Transverse sections of WT (A) or stu
2/2 (B) posterior medial
fins at 32 hpf, fluorescently immunostained for Fras1 (green), p63
(pink) and DAPI (blue). The extent of relative proximal extension
of Fras1 protein appears reduced in stu
2/2 embryos (B) compared
to WT (A). Extent of Fras1 staining is delineated by adjacent white
line. Note that in the mutant, levels of Fras1 protein in the smaller
domain appear correspondingly higher.
Found at: doi:10.1371/journal.pgen.1000907.s005 (0.74 MB TIF)
Figure S6 Nature of molecular lesions in nel alleles. (A–B)
Sequence chromatograms of hmcn1 cDNA from nel
tq207/tq207 (A)
and nel
fr22/fr22 (B) are shown with mutant sequence given below the
WT sequence above. Whilst the nel
tq207 allele displays a nonsense
mutation, the nel
fr22 allele showed double peaks from nucleotide
8538 onwards, suggestive of aberrant splicing. One of the two
transcripts generated appears as if spliced at sites used in the WT
allele and the other lacked the last 20 bp of exon 55 suggesting
generation of a novel splice site 20 bp further upstream from the
normal end of exon 55. (C) Sequencing the genomic region
around the end of exon 55 in nel
fr22/fr22 mutants revealed a T.A
transversion within the coding region and 17 bp upstream of the
end of exon 55 (8541T.A). This has a two-fold effect, generating
a nonsense mutation Y2847* and secondly converting the genomic
sequence from 8538-gtat-8541 sequence to 8538-gtaa-8541, a
consensus splice site. (D–G) Diagrams of the aberrant splicing at
the end of exon 55 in WT and nel
fr22/fr22 mutants. In WT embryos,
splicing occurs at the nucleotides shown (D; exon sequence is given
in uppercase, intron sequence in lowecase.) to yield the sole WT
transcript (E; partial sequence given with the translation below). In
the mutant, two transcripts (denoted M1 and M2) are generated,
M1 occurring at the WT location, and a second, M2, generated
due to a novel splice donor consensus sequence (F). The cDNA
sequences of both M1 and M2 are given with the translation below
(G). In M1 the T.A yields an in frame nonsense mutation whilst
the same mutation also leads to some splicing giving rise to the M2
transcript which deletes the last 20 nt of exon 55, creating a
frameshift which would be predicted to introduce 10 erroneous
amino acids followed by a stop codon.
Found at: doi:10.1371/journal.pgen.1000907.s006 (0.60 MB TIF)
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